Mark McCamish

Mark McCamish Overview

Investor Type Angel
Investments 1
Portfolio 1

Mark McCamish General Information


Dr. Mark McCamish serves as President, Chief Executive Officer & Board Member at Forty Seven. He is also an angel investor. He is an international expert in biosimilars and biologics. Mark is passionate about mentoring and developing people while focusing on meeting patient needs through efficient, commercially viable efforts. He is a senior executive with extensive experience at multiple companies including Protein Design Labs, Abbott, Amgen and Novartis-Sandoz. He led pioneering efforts in filing and launching biosimilars worldwide. He has demonstrated a commercial mindset in establishing research and development strategies leading to approvals and commercial success in multiple therapeutic areas and regulatory categories including biologics, biosimilars, drugs, devices and medical foods. He held professorships at the University of California, Davis and The Ohio State University. After completing his Ph.D. in Nutritional Sciences from Penn State and M.D. from the University of California, Los Angeles, he completed Residency and Fellowship Training at the University of California, Davis. Mark received his Bachelor's and Master's degrees from University of California, Santa Barbara.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 1490 O'Brien Drive
  • Suite A
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Mark McCamish Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000 0000000000 07-May-2017 0000 00000 00000 Biotechnology Pre-Clinical Trials
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mark McCamish Team (1)

Name Title Deals Funds Boards Office
Mark McCamish Ph.D Angel Investor 0 Menlo Park, CA

Mark McCamish Co-Investors (4)

To view Mark McCamish‘s complete co-investor history, request access »
Name With Exits Lead Partner Series Industry
Development Bank of Wales 1 0 Series chart Industry bar
Innovate UK 0 0 Series chart Industry bar
Midven (Birmingham) 0 Series chart Industry bar
UK Innovation & Science Seed Fund 0 0 Series chart Industry bar